Postoperative Air Leak Clinical Trial
Official title:
The Efficacy of OK-432 Pleurodesis on Postoperative Air Leak
The purpose of this study is (1) The success rate of OK-432 pleurodesis after thoracic
surgery that air leak over 48 hours (2)The side effects and treatments of OK-432
pleurodesis.
[Methods] This study was a prospective, randomized, open-label, controlled study to evaluate
the effectiveness of OK-432 pleurodesis of persistent air Leak after pulmonary Resection.
The adult patient have persistent air leak >48 hours after thoracic surgery, will randomized
to OK-432 pleurodesis (OK-432 group) or normal saline pleurodesis (NS group). The trial will
be conduct from May 25, 2015 to May 25, 2018 in the Department of Surgery at national Taiwan
University Hospital, a medical center. The study protocol was approved by the hospitals'
Institutional Review Boards. A total of 80 cases, the subjects will be the hospital thoracic
surgery ward and received outpatient programs. Eligible Subjects : adults (minimum age> 20
years; maximum age ≦ 70 years old) patients with thoracic surgery and over48 hours of
continuous air leak. The exclusion criteria include: penicillin allergy,primary
pneumothorax, esophageal cancer, immune dysfunction, those who can not sign a consent form,
and pregnant or lactating, other serious concomitant illness such as uremia or liver
cirrhosis. Study steps: eligible Patients will randomize according to computer-generated
random numbers, with 1:1 ratio in sequentially numbered, sealed envelopes by a study nurse
who was masked to the study. Randomization envelopes were opened, and randomization was
performed by the study nurse after informed consent was obtain. Eligible inpatients were
randomized to the OK-432 group or the normal saline (NS) group,each group are 40 cases.
All subjects were observed by the physician who was masked to the study, about air leak stop
time, chest tube removal time, discharge time, outpatient chest X-ray, pulmonary function
tests as necessary. cases if persistent air leak more than seven days, the attending
physician determines whether pleurodesis again or surgery or other medical treatment.
Finally, the researcher who do not know groups will collection data by "air leak case record
form" including diagnosis, surgical site,the start and end time of the surgery, the use of
antibiotics, discomfort problems (pain , stomach discomfort, cough, fever> 38 ℃, allergic
reactions and respiratory discomfort), postoperative air leak time, air leak stop time ,
chest tube removal time, discharge time, the data will be use SPSS20.0 version of the
statistical software package, and T-test, pair T-test ,Anova ,linear correlation statistical
methods for analysis.
Outcome measures: OK-432 success rate, OK-432 side effects, air leak time, chest tube remove
time, length of hospital stay.
[Background and Objective] :Air leak produced after thoracic surgery is a common
phenomenon.Prolonged chest tube placement can lead to empyema or infection, and extended
hospitalization or even death. In 2010 many researchers reported that The incidence of lung
resection produce air leak about 8-26% (Singhal et al., 2010), and even up to 50% (Mueller &
Marzluf, 2014).How to effectively treatment is still not clear.The chemical pleurodesis is
an effective option in management of air leak.There are several chemical agents for
pleurodesis, such as tetracycline and minocycline, talc, Taurolidine, bleomycin,
iodopovidone, picibanil (OK-432), silver nitrate, quinacrine. What kind of chemical agent
effective remain controversial. A study evaluated after thoracoscopic operation for primary
spontaneous pneumothorax the safety and efficacy of chemical pleurodesis with a comparison
between minocycline and OK-432. The OK-432 pleurodesis (19 patients) as the primary
treatment and the primary success rate was 95%.(How et al., 2014).Another retrospective
case-control study examining post-isolated lobectomies and bilobectomies by thoracotomy of
Persistent air leak,sclerosis (talc, bleomycin, minocycline, doxycycline)for the treatment
of prolonged air leak was successful in 40 of 41 patients (the success rate of 97.6%)
(Liberman et al., 2010). The prolonged air leaks after major pulmonary resection still no
empirical treatment of clinical research.
Hypothesis: patients were persistent air leak after 48 hours chest surgery will perform
OK-432 pleurodesis .The chest tube time can reduce and length of hospital stay. Extended
applications can significantly reduce medical costs and manpower, and to explore OK -432
pleurodesis side effects and treatment.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03905408 -
Pleurodesis Using Hypertonic Glucose to Treat Post-operative Air Leaks
|
Phase 1 | |
Recruiting |
NCT05628415 -
Comparison Between the Non-powered AEON™ Endostapler and Echelon FLEX™ Powered Plus Stapler With Regards to the Closure of Lung Tissue After Lung Resection in the Presence of Severe Lung Emphysema
|
N/A | |
Recruiting |
NCT05638113 -
Prolonged Air Leakage After Major Lung Resection
|
N/A | |
Completed |
NCT04065880 -
Neoveil® Versus TachoSil® for the Treatment of Pulmonary Air Leaks Following Lung Operation
|
N/A |